Bank of America Corp DE grew its stake in ICU Medical, Inc. (NASDAQ:ICUI – Get Rating) by 13.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 151,188 shares of the medical instruments supplier's stock after buying an additional 17,788 shares during the quarter. Bank of America Corp DE owned approximately 0.63% of ICU Medical worth $33,661,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Mutual of America Capital Management LLC boosted its position in shares of ICU Medical by 1.8% in the first quarter. Mutual of America Capital Management LLC now owns 18,182 shares of the medical instruments supplier's stock worth $4,048,000 after purchasing an additional 328 shares during the period. Treasurer of the State of North Carolina raised its holdings in ICU Medical by 1.7% during the first quarter. Treasurer of the State of North Carolina now owns 7,340 shares of the medical instruments supplier's stock valued at $1,634,000 after acquiring an additional 123 shares during the period. Canvas Wealth Advisors LLC lifted its position in shares of ICU Medical by 15.3% in the first quarter. Canvas Wealth Advisors LLC now owns 5,076 shares of the medical instruments supplier's stock valued at $1,066,000 after acquiring an additional 673 shares in the last quarter. Commerce Bank boosted its stake in shares of ICU Medical by 20.7% in the first quarter. Commerce Bank now owns 3,620 shares of the medical instruments supplier's stock worth $806,000 after acquiring an additional 620 shares during the period. Finally, State Street Corp grew its position in shares of ICU Medical by 2.0% during the fourth quarter. State Street Corp now owns 559,026 shares of the medical instruments supplier's stock worth $132,679,000 after purchasing an additional 11,038 shares in the last quarter. 90.20% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have weighed in on ICUI. KeyCorp dropped their price target on ICU Medical from $230.00 to $225.00 in a research note on Tuesday, August 9th. StockNews.com upgraded shares of ICU Medical from a "sell" rating to a "hold" rating in a research report on Monday, September 5th. Finally, Raymond James decreased their price target on shares of ICU Medical from $208.00 to $190.00 and set an "outperform" rating on the stock in a research note on Tuesday, August 9th.

ICU Medical Stock Down 0.6 %

ICU Medical (NASDAQ:ICUI – Get Rating) last issued its quarterly earnings data on Monday, August 8th. The medical instruments supplier reported $1.13 EPS for the quarter, missing analysts' consensus estimates of $1.36 by ($0.23). The business had revenue of $561.00 million during the quarter, compared to analysts' expectations of $569.30 million. ICU Medical had a return on equity of 6.97% and a net margin of 0.31%. The business's quarterly revenue was up 74.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.57 earnings per share. As a group, equities analysts predict that ICU Medical, Inc. will post 5.23 EPS for the current fiscal year.

ICU Medical Profile

(Get Rating)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.

Featured Stories

• Get a free copy of the StockNews.com research report on ICU Medical (ICUI)
• EV Battery Maker Freyr Set For Major Global Expansion
• MarketBeat: Week in Review 9/26 – 9/30
• This Is A Memorable Time To Buy Into Micron Technology
• Declining Profits Challenge the CarMax Value Proposition
• Thor Industries Hammers Out A Bottom

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI – Get Rating).

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.